Caries Lesion Activity in Orthodontic Patients - Calcivis System
Monitoring of Caries Lesion Activity in Orthodontic Patients With the Calcivis System
1 other identifier
interventional
36
1 country
1
Brief Summary
This is a prospective, single-centre clinical study to monitor caries lesion activity in orthodontic patients with the Calcivis System over a 12 week period. Dentists will identify patients who have had dental appliances in place for a minimum of 12 months and have visible white spot lesions on the anterior surfaces of incisors and / or canines at de-bond. Following de-bond, images of the tooth surface will be taken with the Calcivis System. Presence or absence of elevated luminescence on the images will indicate activity / inactivity. Only patients with at least one tooth identified as active with the Calcivis System will continue in the study and be followed up at 2, 4, 8 and 12 weeks de-bond. Images of the active teeth will be taken with the Calcivis System as before, at each follow-up visit. The percentage of teeth showing luminescence using the Calcivis System will be calculated and summarised for all subjects for each post-baseline visit, and additionally by Investigator. This will then be summarised over all subjects for each post-baseline visit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2016
CompletedFirst Posted
Study publicly available on registry
May 13, 2016
CompletedStudy Start
First participant enrolled
February 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 5, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2018
CompletedResults Posted
Study results publicly available
February 28, 2019
CompletedFebruary 28, 2019
June 1, 2018
1.3 years
May 12, 2016
February 19, 2019
February 26, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Presence or Absence of Elevated Luminescence
Percentage of active teeth showing luminescence (as measured by Calcivis System imaging) over time
0, 2, 4, 8 and 12 weeks
Presence or Absence of Elevated Luminescence
Percentage of active teeth showing luminescence (as measured by Calcivis System imaging) over time, per Investigator
0, 2, 4, 8 and 12 weeks post de-bond
Secondary Outcomes (4)
Number of Non-patient Related Adverse Events With the Calcivis System
0 days, 2, 4, 8 and 12 weeks
Patient Experience
Baseline
Patient Experience
Final Visit - either 8 or 12 weeks post debond
User Questionnaires
Baseline visit
Study Arms (1)
Active post-othodontic lesions
OTHERImaging with the Calcivis System
Interventions
Following de-bond, and identification of active post-orthodontic white spot lesions at baseline with the Calcivis System, each active tooth will be again be imaged at 2, 4, 8 and 12 weeks. Both black \& white and luminescent images images of the teeth are taken. The images of each tooth are overlaid and a resulting demineralization map of the tooth produced, indicating areas of elevated bioluminescence corresponding to free calcium ions on the surface of the tooth (active caries)
Eligibility Criteria
You may qualify if:
- Patient must be ≥ 12 years old
- Patient must have had orthodontic appliances placed on the upper incisors and / or canines for at least 12 months, and be ready for de-bond
- Patient must have at least one, active white spot lesion identified by the Calcivs System immediately post de-bond
- Patient and / or parent or guardian must be willing and able to give written informed consent
- Patient and / or parent or guardian must be willing and able to adhere to study schedule
You may not qualify if:
- Any Patient with recent tooth bleaching (within previous two weeks of imaging with the Calcivis System) or within the follow-up period
- Any patient currently taking part in a clinical research study, or who has taken part in a clinical research study in the previous three months
- Pregnant and / or nursing mothers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Calcivis Ltdlead
- Medsource UK Ltd.collaborator
Study Sites (1)
Edinburgh Dental Institute
Edinburgh, EH3 9HA, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Director of Clinical Research
- Organization
- Calcivis Ltd
Study Officials
- STUDY DIRECTOR
Aman Ulhaq, BDS, MFDS, MSc, MOrtho
Edinburgh Dental Institutie
- PRINCIPAL INVESTIGATOR
Niall McGuinness, FDS, MOrth, MSCD, DDS, PhD
Edinburgh Dental Institute
- PRINCIPAL INVESTIGATOR
Eamon Howard-Bowles, BDS, MFDS, PG Cert
Edinbuirgh Dental Institute
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2016
First Posted
May 13, 2016
Study Start
February 15, 2017
Primary Completion
June 5, 2018
Study Completion
June 5, 2018
Last Updated
February 28, 2019
Results First Posted
February 28, 2019
Record last verified: 2018-06
Data Sharing
- IPD Sharing
- Will not share